GloveCare: a pilot study in preparation for a cluster crossover randomized controlled trial of non-sterile glove-based care in preventing late-onset infection in the NICU.

Late-onset infection Neonatal intensive care unit Nonsterile gloves

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
23 Mar 2023
Historique:
received: 24 02 2022
accepted: 01 03 2023
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

Late-onset infections (LOI) are a major cause of morbidity and mortality among patients in the neonatal intensive care unit (NICU). Gloving after hand hygiene may be a pragmatic approach to prevent infections that arise when healthcare workers' hands transmit pathogens to neonates. To determine the feasibility of conducting a multicenter, open-labeled randomized controlled trial (RCT) to determine whether a protocol that requires healthcare workers (HCWs) in a level 3 NICU to wear non-sterile gloves plus hand hygiene reduces the occurrence of a late-onset infection, compared to hand hygiene alone. In this single-center pilot study, we recruited neonates admitted to the McMaster Children's Hospital NICU from June 2017 to May 2018. The NICU was randomized to begin with the standard (control) arm for 6 months (June 2017 to Dec 2017), followed by the gloving (GloveCare) arm for 6 months (Jan 2018 to July 2018), with a 2-week washout period in-between to educate healthcare workers about gloving. We measured numerous feasibility outcomes including enrollment, event rate, and compliance with hand hygiene (Moment 1: before patient contact, Moment 2: before clean procedure, Moment 3: after body fluid contact, Moment 4: after patient contact) and gloving compliance. We enrolled 750 neonates (390 Standard care, 360 GloveCare) and achieved 100% enrollment. We found higher hand hygiene compliance during the standard care arm compared to the GloveCare for all four moments of hand hygiene (Moment 1: 87% vs 79%, OR=1.86 (1.34, 2.59); Moment 2: OR=1.73 (1.00, 3.01); Moment 3: OR=1.11 (0.62, 1.98); Moment 4: OR=1.65 (1.27, 2.14)). We developed and validated a method to calculate glove compliance, which ranged from 48 to 85%, and was highest for moment 3 (doffing after a procedure or body fluid exposure risk). No adverse events were documented for patients or staff. Reduction in hand hygiene compliance in the GloveCare arm presents a pragmatic challenge in ascertaining the effectiveness of gloving to prevent LOI. Most LOIs were non-sterile-site infections, which is considered a less patient-important or clinically relevant outcome compared to sterile-site LOI. Ensuring efficient collection and validation of hand hygiene and gloving data is imperative. The pilot study demonstrated the feasibility of this intervention though modifications to improve hand hygiene compliance during GloveCare will be important prior to a multicenter cluster RCT to assess the efficacy of non-sterile glove-based care in preventing LOI in the NICU. Clinicaltrials.gov, NCT03078335.

Sections du résumé

BACKGROUND BACKGROUND
Late-onset infections (LOI) are a major cause of morbidity and mortality among patients in the neonatal intensive care unit (NICU). Gloving after hand hygiene may be a pragmatic approach to prevent infections that arise when healthcare workers' hands transmit pathogens to neonates.
OBJECTIVE OBJECTIVE
To determine the feasibility of conducting a multicenter, open-labeled randomized controlled trial (RCT) to determine whether a protocol that requires healthcare workers (HCWs) in a level 3 NICU to wear non-sterile gloves plus hand hygiene reduces the occurrence of a late-onset infection, compared to hand hygiene alone.
METHODS METHODS
In this single-center pilot study, we recruited neonates admitted to the McMaster Children's Hospital NICU from June 2017 to May 2018. The NICU was randomized to begin with the standard (control) arm for 6 months (June 2017 to Dec 2017), followed by the gloving (GloveCare) arm for 6 months (Jan 2018 to July 2018), with a 2-week washout period in-between to educate healthcare workers about gloving. We measured numerous feasibility outcomes including enrollment, event rate, and compliance with hand hygiene (Moment 1: before patient contact, Moment 2: before clean procedure, Moment 3: after body fluid contact, Moment 4: after patient contact) and gloving compliance.
RESULTS RESULTS
We enrolled 750 neonates (390 Standard care, 360 GloveCare) and achieved 100% enrollment. We found higher hand hygiene compliance during the standard care arm compared to the GloveCare for all four moments of hand hygiene (Moment 1: 87% vs 79%, OR=1.86 (1.34, 2.59); Moment 2: OR=1.73 (1.00, 3.01); Moment 3: OR=1.11 (0.62, 1.98); Moment 4: OR=1.65 (1.27, 2.14)). We developed and validated a method to calculate glove compliance, which ranged from 48 to 85%, and was highest for moment 3 (doffing after a procedure or body fluid exposure risk). No adverse events were documented for patients or staff.
DISCUSSION CONCLUSIONS
Reduction in hand hygiene compliance in the GloveCare arm presents a pragmatic challenge in ascertaining the effectiveness of gloving to prevent LOI. Most LOIs were non-sterile-site infections, which is considered a less patient-important or clinically relevant outcome compared to sterile-site LOI. Ensuring efficient collection and validation of hand hygiene and gloving data is imperative.
CONCLUSION CONCLUSIONS
The pilot study demonstrated the feasibility of this intervention though modifications to improve hand hygiene compliance during GloveCare will be important prior to a multicenter cluster RCT to assess the efficacy of non-sterile glove-based care in preventing LOI in the NICU.
TRIAL REGISTRATION BACKGROUND
Clinicaltrials.gov, NCT03078335.

Identifiants

pubmed: 36959636
doi: 10.1186/s40814-023-01271-9
pii: 10.1186/s40814-023-01271-9
pmc: PMC10035220
doi:

Banques de données

ClinicalTrials.gov
['NCT03078335']

Types de publication

Journal Article

Langues

eng

Pagination

50

Subventions

Organisme : New Investigator's Fund
ID : 16390

Informations de copyright

© 2023. The Author(s).

Références

Genes Dis. 2018 Feb 28;5(1):24-26
pubmed: 30258931
Pediatrics. 2004 Aug;114(2):348-55
pubmed: 15286215
Am J Infect Control. 2019 May;47(5):492-497
pubmed: 30616932
Am J Infect Control. 2016 Dec 1;44(12):1481-1485
pubmed: 27665030
Pediatrics. 2003 Apr;111(4 Pt 2):e519-33
pubmed: 12671172
Am J Infect Control. 2006 Apr;34(3):95-9
pubmed: 16630970
Infect Control Hosp Epidemiol. 2009 Jul;30(7):611-22
pubmed: 19508124
Infect Control Hosp Epidemiol. 2013 Feb;34(2):207-10
pubmed: 23295569
J Hosp Infect. 2017 Feb;95(2):169-174
pubmed: 27634563
Pediatrics. 2010 Mar;125(3):437-46
pubmed: 20123773
J Perinatol. 2010 Mar;30(3):170-81
pubmed: 19940855
Peptides. 2003 May;24(5):779-88
pubmed: 12895666
Infect Control Hosp Epidemiol. 2009 Mar;30(3):222-5
pubmed: 19199530
Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F257-63
pubmed: 25425653
Crit Care Med. 2009 Jul;37(7):2167-73; quiz 2180
pubmed: 19487942
J Paediatr Child Health. 2018 Dec;54(12):1314-1320
pubmed: 29888413
MCN Am J Matern Child Nurs. 2017 Nov/Dec;42(6):326-331
pubmed: 29049057
Crit Rev Clin Lab Sci. 2017 Sep;54(6):358-413
pubmed: 29017389
Neonatal Netw. 2011 May-Jun;30(3):165-74
pubmed: 21576051
Infect Control Hosp Epidemiol. 1996 Jan;17(1):47-52
pubmed: 8789688
Infect Control Hosp Epidemiol. 2015 Aug;36(8):957-62
pubmed: 25903555
Infect Control Hosp Epidemiol. 2002 Dec;23(12 Suppl):S3-40
pubmed: 12515399
Infect Control Hosp Epidemiol. 2004 Mar;25(3):192-7
pubmed: 15061408
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Med Microbiol. 2013 Apr;62(Pt 4):623-629
pubmed: 23329322
Curr Opin Infect Dis. 2017 Jun;30(3):281-288
pubmed: 28306563
Arch Dis Child Fetal Neonatal Ed. 2004 Jul;89(4):F336-40
pubmed: 15210670
JAMA Pediatr. 2014 Oct;168(10):909-16
pubmed: 25111196
JAMA. 2004 Nov 17;292(19):2357-65
pubmed: 15547163
Heart Lung. 2000 Mar-Apr;29(2):136-42
pubmed: 10739490
Acta Paediatr. 2014 Oct;103(10):1053-6
pubmed: 24974740
CMAJ. 2009 Oct 13;181(8):469-76
pubmed: 19667033

Auteurs

Sarah Khan (S)

McMaster University, Hamilton, Canada. khan259@mcmaster.ca.
McMaster Children's Hospital, 1200 Main St. West, 3A, Hamilton, ON, Canada. khan259@mcmaster.ca.

Kara K Tsang (KK)

London School of Tropical Medicine and Hygiene, London, UK.

Zheng Jing Hu (ZJ)

McMaster University, Hamilton, Canada.

Beata Mostowiak (B)

University Health Network, Toronto, Canada.

Salhab El Helou (S)

McMaster University, Hamilton, Canada.

Michelle Science (M)

University of Toronto, Toronto, Canada.

David Kaufman (D)

University of Virginia, Charlottesville, VA, USA.

Jeffrey Pernica (J)

McMaster University, Hamilton, Canada.

Lehana Thabane (L)

McMaster University, Hamilton, Canada.

Dominik Mertz (D)

McMaster University, Hamilton, Canada.

Mark Loeb (M)

McMaster University, Hamilton, Canada.

Classifications MeSH